miR‐486 improves fibrotic activity in myocardial infarction by targeting SRSF3/p21‐Mediated cardiac myofibroblast senescence

The regulation of fibrotic activities is key to improving pathological remodelling post‐myocardial infarction (MI). Currently, in the clinic, safe and curative therapies for cardiac fibrosis and improvement of the pathological fibrotic environment, scar formation and pathological remodelling post‐MI...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hongyi, Lv, Luocheng, Liang, Ruoxu, Guo, Weimin, Liao, Zhaofu, Chen, Yilin, Zhu, Kuikui, Huang, Ruijin, Zhao, Hui, Pu, Qin, Yuan, Ziqiang, Zeng, Zhaohua, Zheng, Xin, Feng, Shanshan, Qi, Xufeng, Cai, Dongqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575141/
https://www.ncbi.nlm.nih.gov/pubmed/36117396
http://dx.doi.org/10.1111/jcmm.17539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575141/
https://www.ncbi.nlm.nih.gov/pubmed/36117396
http://dx.doi.org/10.1111/jcmm.17539

Ejemplares similares